Catalyst Wire Dossier Catalyst Wire Dossier

RENABLATE-II Renal Denervation System

· Biosense Webster, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RENABLATE-II Renal Denervation System, covering 2015-12-07 to 2015-12-07. Get the full timeline:

Most recent: Clinical Trial Update: RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157 [Phase 1]

See pricing